Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

HUMULIN R 500 UNIT/ML VIAL

Insulin human
$71.1742per ML

Strength

500 [iU]/mL

Manufacturer

Eli Lilly and Company

NDC

00002850101

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

10/22/2025

Active Ingredients

INSULIN HUMAN

Approval Type

Biologic (BLA)

FDA Application

BLA018780

On Market Since

3/31/1994

Pharmacological Classes

Insulin
Insulin

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.1%

3Y

+0.2%

5Y

-0.2%

All

+76.6%

Generic Alternatives

1 alternative • Same active ingredient

HUMULIN R 500 UNIT/ML KWIKPEN
Brand
00002882427•Eli Lilly and Company
$91.6633
+29% more

Related Drugs

Same classification

NOVOLIN R 100 UNIT/ML VIAL
Brand
00169183311•Novo Nordisk
$4.6226
per ML
NOVOLIN N 100 UNIT/ML VIAL
Brand
00169183411•Novo Nordisk
$4.6249
per ML
NOVOLIN 70-30 100 UNIT/ML VIAL
Brand
00169183711•Novo Nordisk
$4.6290
per ML
AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE
Brand
47918087490•Mannkind Corporation
$5.1957
per EA
NOVOLIN R 100 UNIT/ML FLEXPEN
Brand
00169300315•Novo Nordisk
$5.8194
per ML
NOVOLIN 70-30 FLEXPEN
Brand
00169300715•Novo Nordisk
$5.8261
per ML
NOVOLIN N 100 UNIT/ML FLEXPEN
Brand
00169300415•Novo Nordisk
$5.8268
per ML
LANTUS 100 UNIT/ML VIAL
Brand
00088222033•Sanofi-Aventis U.S. LLC
$6.1584
per ML
LANTUS SOLOSTAR 100 UNIT/ML
Brand
00088221905•Sanofi-Aventis U.S. LLC
$6.1661
per ML
NOVOLOG MIX 70-30 VIAL
Brand
00169368512•Novo Nordisk
$6.9325
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy